NCT00226265

Completed

The Short Form-36: Pre- Versus Post-Surgical Administration ...

Weill Medical College of Cornell University Source

Compare

Other study identifiers

Sponsor study identifier

1203-069

Study Type

observational

Actual enrollment (reported)

50

Locations

1 country

Sites

1

Timeline

Study Start

January 1999

Actual (reported)

Primary Completion

December 2006

Actual (reported)

Study Completion

September 2007

Actual (reported)

Brief Summary

The purpose of this study is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 50 participants
Study completion date: September 2007
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 1999
Actual (reported)
First Submitted
September 14, 2005
Actual (reported)
First Posted
September 26, 2005
Actual (reported)
Primary Completion
December 2006
Actual (reported)
Study Completion
September 2007
Actual (reported)

Last Updated: February 23, 2017
Status Verified: February 2017
Last Update Submitted: February 17, 2017

Conditions

Coronary Artery Bypass Grafting Heart Diseases Heart Valve Diseases

Keywords

Cardiac surgery patientsQuality of LifeRecall biasAortic valve replacementMitral valve replacementTricuspid valve replacementCoronary artery bypass graft surgery

Eligibility Criteria

Age18 Years - 100 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Cardiac Surgery Patients at New York Presbyterian Hospital-Weill Cornell Medical College

You may qualify if:

Cardiac surgery patients who are between the ages of 18 and 100

Sponsors & Collaborators

Weill Medical College of Cornell University
Otherlead

Study Sites (1)

The New York Presbyterian Hospital-Weill Medical Center

New York, New York, 10021, United States

MeSH Terms

Conditions

Heart DiseasesHeart Valve Diseases

Condition Hierarchy (Ancestors)

Cardiovascular Diseases

Study Officials

Mary E Charlson, MD
Weill Medical College of Cornell University
PRINCIPAL INVESTIGATOR

Enrollment

50 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Principal Investigator

Study Record Dates

First Submitted

September 14, 2005

First Posted

September 26, 2005

Study Start

January 1999

Actual (reported)

NCT04124120

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Not ApplicableRecruiting

NCT06467513

To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications

Phase 4Unknown

NCT00700947

Using Beta Blockers to Treat Mitral Regurgitation

Phase 1Terminated

NCT00013949

Cardiovascular Vulnerability to Particulate Exposure

Completed

NCT00001740

Evaluation of Left Ventricular Volumes by Real-Time 3-Dimensional Echocardiography

Completed

NCT00001638

Magnetic Resonance Imaging of the Blood Vessels of the Heart

Completed

Are English speaking

Able to give consent

Undergoing cardiac surgery including (but not limited to):

Aortic valve replacement (AVR)

Mitral valve replacement (MVR)

Tricuspid valve replacement (TVR)

Coronary artery bypass graft (CABG).

You may not qualify if:

Non-cardiac surgery patients

Contact the study team to confirm eligibility.

Primary Completion

December 2006

Actual (reported)

Study Completion

September 2007

Actual (reported)

Last Updated

February 23, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00226265
Data provider: ClinicalTrials.gov
Source updated: 2017-02-23
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:21:47 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations